Latin America Next Generation Sequencing Market- Opportunity Analysis and Industry Forecast (2020-2027)
Meticulous Research®– leading global market research company published a research report titled “Latin America Next Generation Sequencing Market by Type (Consumables, NGS Platform), Sequencing Type (Whole Genome, Targeted), Technology (Sequencing by Synthesis, Sequencing by Ligation), Application (Clinical, Research), End User - Forecast to 2027”.
According to this latest publication from Meticulous Research®, the Latin
America NGS market is expected to grow at a CAGR of 14.3% from 2020 to 2027 to
reach $714.8 million by 2027. The growth in NGS market in Latin America is
mainly attributed to the technological advancements in sequencing procedures,
surge in genome mapping programs, and increase in drug discovery platforms
demanding NGS technology. In addition, the growth in personalized medicine
research, growing government initiatives for large-scale genomic sequencing
projects, and emergence of cloud computing as a potential data management
service further supports the market growth.
The Latin America next
generation sequencing market study presents historical market data in terms of
values (2018 and 2019), estimated current data (2020), and forecasts for 2027 –
by type (consumables, NGS platform, software), sequencing type (whole genome,
targeted), technology (sequencing by synthesis, sequencing by ligation),
application (clinical, research), and end user. The study also evaluates
industry competitors and analyzes their market share at country level.
Scope of the Report:
Latin
America NGS Market by Type
·
Consumables
o Sample Preparation Consumables
§ DNA Fragmentation & Amplification
§ Library Preparation & Target Enrichment
§ Quality Control
§ Other Consumables
(Note: Other consumables include vials, pipettes, containers, trays, tubes,
and more)
·
NGS
Platforms/Instruments
o Illumina NGS Platforms/Instruments
o Thermo Fisher Scientific NGS Platforms/Instruments
o Pacific Biosciences NGS Platforms/Instruments
o Oxford Nanopore NGS Platforms/Instruments
o Others
(Note: Other instruments used during NGS include PCR systems, automated liquid
handling systems, electrophoresis devices, library preparation devices, and
more)
·
Software
·
Services
Latin
America NGS Market by Sequencing Type
·
Whole Genome Sequencing
·
Whole Exome Sequencing
·
Targeted Sequencing
·
Others
(Note: Other sequencing approaches include RNA sequencing, de-novo
sequencing, degradome sequencing, miRNA sequencing, chromatin
immunoprecipitation (ChIP) sequencing, and methylation sequencing)
Latin
America NGS Market by Technology
·
Sequencing by Synthesis
·
Ion Semiconductor
Sequencing
·
Sequencing by Ligation
·
Single-Molecule
Real-Time Sequencing
·
Nanopore Sequencing
·
Others
(Note: Other sequencing technologies include Polony sequencing,
pyrosequencing, DNA nanoball sequencing, and true Single Molecule Sequencing
(tSMS))
Latin
America NGS Market by Application
·
Clinical Application
o Oncology
o Reproductive Health Diagnostics
§ Non-Invasive Pre-natal Testing
§ Carrier Screening
§ In-Vitro fertilization
§ Newborn Screening
o Cardiovascular
o Others
(Note: Other clinical applications include detection of genetic aberrations
in neurological disorders, rare diseases, metabolic and immune disorders, and
food borne illness)
·
Research Application
o Drug Discovery
o Agriculture & Animal Research
o Others
(Note: Other research applications include food microbiology, microbiota
analysis in beverage industry, and environmental studies)
Latin
America NGS Market by End user
·
Clinical Diagnostic
Laboratories
·
Pharmaceutical &
Biotechnology Companies
·
Academic & Research
Institutes
·
Others
(Note: Other end-users include forensic departments, food companies, and
hospitals)
Latin
America NGS Market by Country
·
Brazil
·
Mexico
·
Argentina
·
Chile
·
Rest of Latin America
Areas
of Focused Research Services in Latin America:
·
Market Access
·
Regulatory
Scenario
·
Top Technology
Trends
·
End User
Perception Analysis
·
Partner
Identification
·
Due Diligence
·
Distribution
Channel Assessment
·
Supply Chain
Analysis
·
Procurement
Practices
·
Key Customer
Assessment
·
Others
Check complete table of contents
with list of table and figures:https://www.meticulousresearch.com/product/latin-america-next-generation-sequencing-market-5106/
Based on type, the consumable segment is estimated to account for
the largest share of the Latin America NGS market in 2020. The large share of
this segment is mainly attributed to the frequent use of consumables during
sequencing procedures.
Based on sequencing type, the targeted sequencing segment
is estimated to account for the largest share of the Latin America NGS market
in 2020. The major share of this segment is primarily due to the higher
adoption of targeted sequencing with capability of the technique to call
variants at lower costs compared to other sequencing technologies, and ability
to generate manageable data volumes with reliable results.
Based on technology, the sequencing by synthesis segment is estimated
to command the major share of the Latin America next-generation sequencing
market in 2020 and is also slated to grow at the fastest CAGR during the
forecast period. The large share of this segment is attributed to the high
accuracy of SBS technology in DNA sequencing, highest yield of error free
throughput, and growing incorporation of this technology in NGS
instrumentation.
Based on end user, the clinical diagnostic laboratories segment
is estimated to account for the largest share of this market in 2020. The large
share of this segment is mainly due to the rising pool of cancer patients
visiting diagnostic laboratories and growing investments in these facilities in
the region.
This research report
analyzes major countries and provides comprehensive analysis for countries like
Brazil, Mexico, Argentina, Chile, and Rest of Latin America. Brazil is
estimated to command the largest share of the Latin America NGS market in 2020.
The growth in this market is expected to be driven by the factors such as
increasing burden of genetic disorders such as cancer in the region, increasing
investments in personalized medicine development, and growing investments by
the major players in this region.
Speak
with Our Analyst: https://www.meticulousresearch.com/speak-to-analyst/cp_id=5106
The key players operating in the
Latin America NGS market are Illumina, Inc. (U.S.), Thermo Fisher Scientific
Inc. (U.S.), Pacific Biosciences of California, Inc. (U.S.), Qiagen N.V.
(Netherlands), Oxford Nanopore Technologies Ltd (U.S.), Bio-Rad Laboratories,
Inc. (U.S.), Beckman Coulter, Inc. (U.S.), PerkinElmer, Inc. (U.S.), F.
Hoffmann-La Roche AG (Switzerland), and 10x Genomics, Inc. (U.S.) among others.
Key questions answered in the report-
· What is the value of
revenue generated from the sale of NGS products in Latin America? At what rate
their demand is expected to grow for the next 5-7 years?
· What was the
historical market for NGS market across Latin America?
· What are the key
factors driving the growth of the Latin America NGS market?
· What are major
opportunities for existing market players and new entrants in the Latin America
NGS market?
· Which are the high
growth market segments in terms of type, sequencing type, technology,
application, end user, and countries?
· Which country holds
the dominant share of the Latin America NGS market and which country offers the
major traction for the vendors operating in this region?
· How is the competitive
landscape in the Latin America NGS market?
· What recent
developments have happened in the Latin America NGS market in recent past?
Which vendors were majorly involved in these developments and how does this
create an impact on their share in the Latin America NGS market?
· Who are the prominent
players in the Latin America NGS market and what share of the market do they
hold?
Contact Us:
Meticulous
Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research

Comments
Post a Comment